MONSEY, N.Y., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Wohl & Fruchter LLP announces that on September 13, 2023, it filed a securities class action lawsuit in the United States District Court for the Southern District of New York (“Court”), captioned Zappia v. Myovant Sciences, Ltd. et al., Case No. 1:23-cv-08097, on behalf of a class (“Class”) of individuals and entities that held common stock of Myovant Sciences, Ltd. (“Myovant”) as of the close of business on January 20, 2023 (“Class Period”), asserting claims under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, and Securities and Exchange Commission Rule 14a-9 promulgated thereunder, in connection with the acquisition of Myovant by Sumitovant Biopharma Ltd. for an unfair price.
Investors are hereby notified that not later than 60 days after the date of this notice, any member of the purported Class may move the Court to serve as lead plaintiff of the purported Class in this action.
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending action, please contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com.
You may also learn more about the action and download a copy of the complaint by visiting:
https://wohlfruchter.com/cases/myovant-sciences-ltd/
About Wohl & Fruchter
Wohl & Fruchter LLP, with offices in New York City and Monsey, has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners.
Contact:
Wohl & Fruchter LLP
Joshua E. Fruchter
Toll Free 866.833.6245
alerts@wohlfruchter.com
www.wohlfruchter.com
